CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET...
Phase 2
Budapest, Hungary and 90 other locations
in each subject population expansion cohort of advanced solid tumors that harbor a ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement. The seco...
Phase 1, Phase 2
Budapest, Hungary and 160 other locations
The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bev...
Phase 3
Budapest, Hungary and 189 other locations
Clinical trials
Research sites
Resources
Legal